Theragnostic Technologies receives grant to expand its graphene-based contrast agent platform to …

Posted on by

The company will demonstrate the preclinical safety and efficacy of a novel graphene-enhanced CT contrast agent for imaging and monitoring in …

See more...

Posted in Materials and tagged .

Leave a Reply

Your email address will not be published. Required fields are marked *